Long noncoding RNA-mediated activation of androgen receptor in prostate cancer

por Petrovics, Gyorgy, Srivastava, Shiv
Publicado 2014

A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges

por Kohaar, Indu, Petrovics, Gyorgy, Srivastava, Shiv
Publicado 2019

Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities

por Tan, Shyh-Han, Petrovics, Gyorgy, Srivastava, Shiv
Publicado 2018

Oncogenic activation of ERG: A predominant mechanism in prostate cancer

por Sreenath, Taduru L, Dobi, Albert, Petrovics, Gyorgy, Srivastava, Shiv
Publicado 2011

Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men

por Farrell, James, Petrovics, Gyorgy, McLeod, David G., Srivastava, Shiv
Publicado 2013

Biomarkers of Aggressive Prostate Cancer at Diagnosis

por Boehm, Brock E., York, Monica E., Petrovics, Gyorgy, Kohaar, Indu, Chesnut, Gregory T.
Publicado 2023

Prostate cancer gene expression signature of patients with high body mass index

por Sharad, Shashwat, Srivastava, Anjali, Ravulapalli, Suma, Parker, Patrick, Chen, Yongmei, Li, Hua, Petrovics, Gyorgy, Dobi, Albert
Publicado 2010

Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1

por Kumar, Parameet, Sharad, Shashwat, Petrovics, Gyorgy, Mohamed, Ahmed, Dobi, Albert, Sreenath, Taduru L., Srivastava, Shiv, Biswas, Roopa
Publicado 2016

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer

por Thangapazham, Rajesh, Saenz, Francisco, Katta, Shilpa, Mohamed, Ahmed A, Tan, Shyh-Han, Petrovics, Gyorgy, Srivastava, Shiv, Dobi, Albert
Publicado 2014

Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India

por Rawal, Sudhir, Young, Denise, Williams, Molly, Colombo, Monica, Krishnappa, Raghunath, Petrovics, Gyorgy, McLeod, David G., Srivastava, Shiv, Sesterhenn, Isabell A.
Publicado 2013

Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men

por Duncan, Allison, Nousome, Darryl, Ricks, Randy, Kuo, Huai-Ching, Ravindranath, Lakshmi, Dobi, Albert, Cullen, Jennifer, Srivastava, Shiv, Chesnut, Gregory T., Petrovics, Gyorgy, Kohaar, Indu
Publicado 2023

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer

por Kohaar, Indu, Li, Qiyuan, Chen, Yongmei, Ravindranath, Lakshmi, Young, Denise, Ali, Amina, Sesterhenn, Isabell A., Rosner, Inger L., Cullen, Jennifer, Srivastava, Shiv, Freedman, Matthew, Petrovics, Gyorgy
Publicado 2020

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status

por Mwamukonda, Kuwong, Chen, Yongmei, Ravindranath, Lakshmi, Furusato, Bungo, Hu, Ying, Sterbis, Joseph, Osborn, David, Rosner, Inger, Sesterhenn, Isabell A., McLeod, David G., Srivastava, Shiv, Petrovics, Gyorgy
Publicado 2009

Prostate cancer marker panel with single cell sensitivity in urine

por Nickens, Kristen P., Ali, Amina, Scoggin, Tatiana, Tan, Shyh‐Han, Ravindranath, Lakshmi, McLeod, David G., Dobi, Albert, Tacha, David, Sesterhenn, Isabell A., Srivastava, Shiv, Petrovics, Gyorgy
Publicado 2015

Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN

por Li, Hua, Mohamed, Ahmed A., Sharad, Shashwat, Umeda, Elizabeth, Song, Yingjie, Young, Denise, Petrovics, Gyorgy, McLeod, David G., Sesterhenn, Isabell A., Sreenath, Taduru, Dobi, Albert, Srivastava, Shiv
Publicado 2015

TMPRSS2- Driven ERG Expression In Vivo Increases Self-Renewal and Maintains Expression in a Castration Resistant Subpopulation

por Casey, Orla M., Fang, Lei, Hynes, Paul G., Abou-Kheir, Wassim G., Martin, Philip L., Tillman, Heather S., Petrovics, Gyorgy, Awwad, Hibah O., Ward, Yvona, Lake, Ross, Zhang, Luhua, Kelly, Kathleen
Publicado 2012

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer

por Sharad, Shashwat, Sztupinszki, Zsófia M., Chen, Yongmei, Kuo, Claire, Ravindranath, Lakshmi, Szallasi, Zoltan, Petrovics, Gyorgy, Sreenath, Taduru L., Dobi, Albert, Rosner, Inger L., Srinivasan, Alagarsamy, Srivastava, Shiv, Cullen, Jennifer, Li, Hua
Publicado 2019

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer

por Sharad, Shashwat, Ravindranath, Lakshmi, Haffner, Michael C, Li, Hua, Yan, Wusheng, Sesterhenn, Isabell A, Chen, Yongmei, Ali, Amina, Srinivasan, Alagarsamy, McLeod, David G, Yegnasubramanian, Srinivasan, Srivastava, Shiv, Dobi, Albert, Petrovics, Gyorgy
Publicado 2014

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer

por Rastogi, Anshu, Tan, Shyh-Han, Mohamed, Ahmed A., Chen, Yongmei, Hu, Ying, Petrovics, Gyorgy, Sreenath, Taduru, Kagan, Jacob, Srivastava, Sudhir, McLeod, David G., Sesterhenn, Isabell A., Srivastava, Shiv, Dobi, Albert, Srinivasan, Alagarsamy
Publicado 2014

Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression

por Gesztes, William, Schafer, Cara, Young, Denise, Fox, Jesse, Jiang, Jiji, Chen, Yongmei, Kuo, Huai-Ching, Mwamukonda, Kuwong B., Dobi, Albert, Burke, Allen P., Moul, Judd W., McLeod, David G., Rosner, Inger L., Petrovics, Gyorgy, Tan, Shyh-Han, Cullen, Jennifer, Srivastava, Shiv, Sesterhenn, Isabell A.
Publicado 2022